Boston Scientific Corp
NYSE:BSX

  • LAST PRICE
    75.5700
  • TODAY'S CHANGE (%)
    0.5700 (0.7600%)
  • Bid / Lots
    74.0000/ 1
  • Ask / Lots
    76.0000/ 1
  • Open / Previous Close
    75.1800 / 75.0000
  • Day Range
    74.4300
    75.6800
  • 52 Week Range
    48.3500
    76.2500
  • Volume
    8,825,296

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Advanced Medical Equipment Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BSX
Boston Scientific Corp
111.1B
63.1x
-1.29%
ISRG
Intuitive Surgical Inc
142.6B
72.6x
+9.70%
GEHC
GE Healthcare Technologies Inc
35.6B
22.7x
---
EW
Edwards Lifesciences Corp
52.4B
37.3x
+14.85%
A
Agilent Technologies Inc
38.0B
30.9x
+9.42%
PHG
Koninklijke Philips NV
25.5B
-28.9x
---
As of 2024-06-01

Company Information

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. The Cardiovascular segment includes Cardiology and Peripheral Interventions. The Company's Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions.

Contact Information

Headquarters
300 Boston Scientific WayMARLBOROUGH, MA, United States 01752-1291
Phone
508-683-4000
Fax
508-650-8923

Executives

Chairman of the Board, President, Chief Executive Officer
Michael Mahoney
Chief Financial Officer, Executive Vice President
Daniel Brennan
Executive Vice President - Human Resources
Wendy Carruthers
Executive Vice President, Group President, MedSurg and Asia Pacific
Arthur Butcher
Executive Vice President, Group President - Cardiology
Joseph Fitzgerald

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$111.1B
Revenue (TTM)
$14.7B
Shares Outstanding
1.5B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.81
EPS
$1.20
Book Value
$13.16
P/E Ratio
63.1x
Price/Sales (TTM)
7.6
Price/Cash Flow (TTM)
37.3x
Operating Margin
18.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.